Arkolith/Insider Trading/SCLX/Form 4

Sorrento Therapeutics, Inc.

10% OwnerScilex Holding Co (SCLX) · full profile →Form 4 · filed Sep 25, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 21, 2023Sell(S)60.1M——1.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 21, 2023Sell(S)4.5M——0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-103527) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML